AlzBiomarker
Alzheimer's Disease vs Control: sAPPβ (Plasma and Serum)
sAPPβ is a secreted peptide produced from APP processing along the "amyloidogenic" pathway. Meta-analysis of three studies did not show a statistically significant difference in the levels of sAPPβ in the plasma of people with Alzheimer's disease and control subjects.
Loading data...